Why does RSV cause wheezing and hyperinflation in infants?

RSV causes wheezing and hyperinflation by obstructing the small airways. It infects ciliated respiratory epithelial cells in the bronchioles, leading to inflammation, edema, increased mucus, and sloughing of necrotic epithelium that forms debris plugs. This creates air trapping through a ball-valve effect, which produces hyperinflation and increases the work of breathing.

What causes syncytia in RSV infection?

Syncytia in RSV are caused by the viral F, or fusion, protein. This protein fuses the viral envelope with the host cell membrane and also causes infected respiratory epithelial cells to fuse with each other. The result is multinucleated giant cells, a classic cytopathic effect and one of the most distinctive high-yield clues for RSV.

How is RSV bronchiolitis diagnosed on exams and in real life?

RSV bronchiolitis is usually diagnosed clinically in a typical infant presentation. Common clues include a winter illness in an infant with URI symptoms that progress to cough, wheezing, tachypnea, retractions, and nasal flaring. If testing is needed, RT-PCR from a nasopharyngeal swab is sensitive, while chest x-ray may show hyperinflation, peribronchial cuffing, or patchy atelectasis in severe or atypical cases.

What is the first-line treatment for RSV bronchiolitis?

The first-line treatment for RSV bronchiolitis is supportive care. Management centers on hydration, oxygen if the infant is hypoxemic, and suctioning of nasal secretions, with ventilatory support if severe. Antibiotics do not help because bronchiolitis is viral unless there is concern for bacterial superinfection, and bronchodilators or steroids are generally not routinely recommended for classic RSV bronchiolitis.

Who should get palivizumab for RSV prevention?

Palivizumab is used as prophylaxis for high-risk infants rather than routine treatment of active infection. Classic high-risk groups include infants with prematurity, chronic lung disease of prematurity, or significant congenital heart disease. It targets the RSV F protein, which is also responsible for fusion and syncytia formation, making palivizumab a key prevention clue for RSV.

Everything You Need to Know About RSV for Step 1

Respiratory syncytial virus (RSV) is one of those “simple” Step 1 bugs that keeps showing up—because it’s extremely testable. It’s the classic cause of bronchiolitis in infants, it has a distinctive diagnostic clue (syncytia), and it forces you to think through airway obstruction physiology (wheezing + hyperinflation) in a way that connects micro, path, peds, and pharm.

Quick ID: What RSV Is (and Why You Care)

RSV is an enveloped, negative-sense, single-stranded RNA virus in the Paramyxoviridae family (same broader family vibe as parainfluenza and measles).

High-yield identifiers

Enveloped → relatively fragile in the environment; spread mainly via respiratory droplets and direct contact (fomites are still important in daycare/hospital settings).
(-)ssRNA → must carry an RNA-dependent RNA polymerase in the virion.
Causes bronchiolitis and pneumonia in infants/young children
Famous for syncytia formation via F (fusion) protein

First Aid cross-reference: Microbiology → Viruses → Respiratory viruses (RSV); Pediatrics → Bronchiolitis; Immunology/Pharm sections for palivizumab.

Virology Deep Dive (Step-Relevant)

Structure & Key Proteins

RSV has two “Step 1 favorite” surface proteins:

Protein	Function	Board-style consequence
F (fusion) protein	Fuses viral envelope with host cell membrane; also fuses infected cells together	Syncytia (multinucleated giant cells), enhanced cell-to-cell spread
G (attachment) protein	Mediates attachment to respiratory epithelium	Tropism for airway epithelium

Buzzword: Syncytia = multinucleated giant cells formed by fused infected cells (a cytopathic effect).
Mechanism: F protein promotes membrane fusion → infected cells merge.

Pathophysiology: Why RSV Causes Wheeze + Increased Work of Breathing

RSV infects ciliated respiratory epithelial cells, especially in the small airways (bronchioles).

Key downstream effects:

Inflammation + edema of bronchiolar walls
Increased mucus production
Sloughing of necrotic epithelium → debris plugs
Air trapping (ball-valve effect) → hyperinflation
Patchy atelectasis can occur from obstruction

How this shows up clinically (connect the dots)

Wheezing: narrowed bronchioles + mucus plugging
Crackles: small airway + alveolar involvement, secretions
Hypoxemia: V/Q mismatch from obstructed/atelectatic regions
Increased work of breathing: nasal flaring, retractions, tachypnea

First Aid cross-reference: Pathology/Physiology of obstructive disease patterns; Pediatrics bronchiolitis.

Epidemiology & Risk Factors (What NBME Loves)

Who gets RSV?

Peak: infants < 2 years, especially 2–6 months
Seasonality: winter (often tested alongside influenza season, but RSV is a pediatric staple)

Risk factors for severe disease

Prematurity (immature lungs + fewer maternal antibodies)
Bronchopulmonary dysplasia
Congenital heart disease
Immunodeficiency
Young age (small airway caliber → big effect from mild swelling)

Classic test stem setting: daycare exposure + winter + infant with wheeze.

Clinical Presentation: Bronchiolitis “Picture”

Typical bronchiolitis

Symptoms

Starts like a URI: rhinorrhea, congestion, low-grade fever
Progresses to lower respiratory signs: cough, wheezing, tachypnea

Signs

Intercostal/subcostal retractions
Nasal flaring
Diffuse wheezes and/or crackles
Poor feeding, dehydration in infants
Apnea can be an early sign in very young infants (especially premature)

Pneumonia (RSV can do both)

More prominent crackles, hypoxemia
Can overlap with bronchiolitis findings

Diagnosis: Mostly Clinical (But Know the Tools)

In real life and on Step 1

Clinical diagnosis is common for typical bronchiolitis.
Testing is often used for infection control/cohorting in hospitals.

Common diagnostic tests

RT-PCR of nasopharyngeal swab (sensitive)
Rapid antigen tests exist but can be less sensitive depending on setting.

Imaging (board relevance)

CXR may show:
- Hyperinflation
- Peribronchial cuffing
- Patchy atelectasis
Not required for straightforward cases; used if severe/atypical.

High-yield pitfall: bronchiolitis is viral—antibiotics don’t help unless there’s concern for bacterial superinfection.

Treatment: Supportive First, Targeted Prevention for High-Risk

Main treatment (most important)

Supportive care

Hydration
Oxygen if hypoxemic
Suctioning of nasal secretions (big impact in infants)
Ventilatory support if severe (HFNC/CPAP/intubation depending on course)

Bronchodilators and steroids: generally not routinely recommended for classic RSV bronchiolitis (Step 2 nuance). Step 1 takeaway: supportive care is the core.

Antivirals (know but don’t overuse)

Ribavirin: historically used in severe RSV, especially in high-risk/immunocompromised patients; limited routine use due to variable benefit and toxicity/administration issues.

Prevention (very high yield)

Palivizumab

Monoclonal antibody against RSV F protein
Used for prophylaxis in high-risk infants (e.g., prematurity, chronic lung disease of prematurity, significant congenital heart disease)

Testable logic chain:
RSV F protein → syncytia + fusion → palivizumab targets F to prevent infection/severe disease.

First Aid cross-reference: Pharm/immunology: monoclonal antibodies; Micro RSV section often mentions palivizumab.

High-Yield Associations & Classic USMLE Clues

Rapid-fire HY facts

RSV = Paramyxovirus, enveloped, (-)ssRNA
F protein → syncytia
Most common cause of bronchiolitis in infants
Wheezing + hyperinflation pattern
Treatment: supportive
Prevention for high risk: palivizumab (anti-F)

Common stem patterns (translate symptoms → diagnosis)

Infant + winter + URI prodrome → wheeze/retractions → RSV bronchiolitis
Premature infant with apnea episodes + mild URI signs → consider RSV early
Question mentions multinucleated giant cells in respiratory epithelium → think RSV (via F protein)

Differential to keep straight

Condition	Typical age	Hallmark	Common confusion point
RSV bronchiolitis	<2 years	Wheeze, retractions, hyperinflation	Often first wheezing episode
Croup (parainfluenza)	6 mo–3 yr	Barking cough, inspiratory stridor	Upper airway (laryngotracheal)
Influenza	any	Abrupt fever, myalgias	Systemic symptoms prominent
Asthma	older kids/teens	Recurrent episodic wheeze	Not usually first-time infant bronchiolitis picture

Mini “First Aid-Style” Memory Hooks (Without the Fluff)

RSV = Retract (retractions in infants)
Syncytia = Stuck-together cells (F protein fusion)
Viral bronchiolitis = Ventilatory support + hydration (supportive care)

Step-Style Questions: What They’re Really Testing

Mechanism question: “Which viral protein causes multinucleated giant cells?”
→ F (fusion) protein
Management question: “Best next step in an infant with RSV bronchiolitis and mild hypoxemia?”
→ Supportive care + oxygen as needed
Prevention question: “Premature infant entering RSV season—what prophylaxis?”
→ Palivizumab
Pathophys question: “Why hyperinflation?”
→ Small airway obstruction from edema/mucus/debris → air trapping

Takeaway Summary (What to Have Memorized)

RSV is an enveloped (-)ssRNA paramyxovirus causing bronchiolitis in infants.
F protein is the star: fusion + syncytia.
Clinical picture: URI → wheeze, tachypnea, retractions, hyperinflation.
Diagnosis is usually clinical; PCR can confirm.
Treatment is supportive; severe cases may need respiratory support.
Palivizumab (anti-F) prevents severe RSV in high-risk infants.